The van Gogh masterpiece ‘The Starry Night’ is more art than science, researchers report
Peer-Reviewed Publication
North America’s smallest falcon, the American Kestrel (Falco sparverius), has declined across the continent since the 1970s, yet the causes continue to stump raptor biologists. A new study published in the Journal of Raptor Research adds a piece to the puzzle with the discovery that in the Northeast, where declines are most alarming, fledglings demonstrate a relatively high survival rate. This paper, titled “Juvenile and Adult Survival Estimates of American Kestrels Throughout the Full Annual Cycle in Eastern North America,” is the first of its kind. No other study has assessed winter survival rates for kestrels at northern latitudes, fledgling survival following nest departure for both males and females, or tracked individual kestrels through multiple seasons in migratory and residential populations. These breakthroughs may help redirect future studies to untapped arenas of inquiry.
Main findings
- Early symptoms of psoriatic arthritis (PsA) often persist for some time before the condition is diagnosed and treated.
- As a result of delays in diagnosing and treating psoriatic arthritis, patients with PsA experience worse disease control when examined three months after diagnosis than patients with other types of arthritis.
- The study's authors say that in the UK, where the study was carried out, improved diagnostic systems are essential. These would involve family doctors being supported to recognise the symptoms of PsA faster and diagnostic scans being offered earlier, allowing treatment to start before joint damage occurs.
A French team coordinated by a scientist at CNRS highlights the harmful impact on sparrow reproduction of chronic exposure to tebuconazole, one of the most widely used fungicides in agriculture in Europe. These findings, recently published in Environmental Research, reveal a direct link between exposure to this fungicide and slower growth, as well as increased mortality, in sparrow chicks, with a greater impact on females.
FAU researchers have been awarded a five-year NIH grant to address the urgent need for a reliable, rapid and affordable self-test for early HIV detection. Expected to cost less than $5, the novel micro-chip technology will detect HIV during the acute infection phase or viral rebound, deliver rapid results in about 40 minutes and remain stable without refrigeration. The handheld device will be battery-powered and operate fully automated, providing true “sample-in-answer-out” functionality that requires minimal user manipulation.